Sanara MedTech Sees Q2 Sales $28.500M-$29.500M vs $28.650M Est

Benzinga Newsdesk www.benzinga.com Positive 82.1%

Neg 0% Neu 0% Pos 82.1%

Sanara MedTech (NASDAQ:SMTI) sees Q2 sales of $28.500 million-$29.500 million vs $28.650 million analyst estimate.

Comments

No comments yet. Be the first!